Guidelines for the treatment of benign prostatic hyperplasia

Yunuo Wu, Michael H. Davidian, Edward M. DeSimone

Research output: Contribution to specialist publicationArticle

2 Citations (Scopus)

Abstract

Benign prostatic hyperplasia (BPH) is a common disorder in men with an incidence that increases with age. BPH often requires therapy when patients begin to experience lower urinary tract symptoms that affect quality of life. Current management strategies involve lifestyle modifications, pharmacotherapy, phytotherapy, and surgical interventions as indicated. Pharmacists are in the unique position of being accessible sources of healthcare information for the BPH patient population. Understanding the symptoms of this disorder and therapy options will be beneficial for pharmacists who have increased chances to answer BPH-related questions from their patients.

Original languageEnglish (US)
Pages36-40
Number of pages5
Volume41
No8
Specialist publicationU.S. Pharmacist
StatePublished - Aug 1 2016

Fingerprint

Drug therapy
Prostatic Hyperplasia
Guidelines
Pharmacists
Phytotherapy
Lower Urinary Tract Symptoms
Therapeutics
Life Style
Quality of Life
Delivery of Health Care
Drug Therapy
Incidence
Population

All Science Journal Classification (ASJC) codes

  • Pharmacy
  • Pharmacology
  • Pharmaceutical Science

Cite this

Guidelines for the treatment of benign prostatic hyperplasia. / Wu, Yunuo; Davidian, Michael H.; DeSimone, Edward M.

In: U.S. Pharmacist, Vol. 41, No. 8, 01.08.2016, p. 36-40.

Research output: Contribution to specialist publicationArticle

Wu, Yunuo ; Davidian, Michael H. ; DeSimone, Edward M. / Guidelines for the treatment of benign prostatic hyperplasia. In: U.S. Pharmacist. 2016 ; Vol. 41, No. 8. pp. 36-40.
@misc{cdf830429d6144b99a49db10bf18afe6,
title = "Guidelines for the treatment of benign prostatic hyperplasia",
abstract = "Benign prostatic hyperplasia (BPH) is a common disorder in men with an incidence that increases with age. BPH often requires therapy when patients begin to experience lower urinary tract symptoms that affect quality of life. Current management strategies involve lifestyle modifications, pharmacotherapy, phytotherapy, and surgical interventions as indicated. Pharmacists are in the unique position of being accessible sources of healthcare information for the BPH patient population. Understanding the symptoms of this disorder and therapy options will be beneficial for pharmacists who have increased chances to answer BPH-related questions from their patients.",
author = "Yunuo Wu and Davidian, {Michael H.} and DeSimone, {Edward M.}",
year = "2016",
month = "8",
day = "1",
language = "English (US)",
volume = "41",
pages = "36--40",
journal = "U.S. Pharmacist",
issn = "0148-4818",
publisher = "Jobson Publishing Corporation",

}

TY - GEN

T1 - Guidelines for the treatment of benign prostatic hyperplasia

AU - Wu, Yunuo

AU - Davidian, Michael H.

AU - DeSimone, Edward M.

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Benign prostatic hyperplasia (BPH) is a common disorder in men with an incidence that increases with age. BPH often requires therapy when patients begin to experience lower urinary tract symptoms that affect quality of life. Current management strategies involve lifestyle modifications, pharmacotherapy, phytotherapy, and surgical interventions as indicated. Pharmacists are in the unique position of being accessible sources of healthcare information for the BPH patient population. Understanding the symptoms of this disorder and therapy options will be beneficial for pharmacists who have increased chances to answer BPH-related questions from their patients.

AB - Benign prostatic hyperplasia (BPH) is a common disorder in men with an incidence that increases with age. BPH often requires therapy when patients begin to experience lower urinary tract symptoms that affect quality of life. Current management strategies involve lifestyle modifications, pharmacotherapy, phytotherapy, and surgical interventions as indicated. Pharmacists are in the unique position of being accessible sources of healthcare information for the BPH patient population. Understanding the symptoms of this disorder and therapy options will be beneficial for pharmacists who have increased chances to answer BPH-related questions from their patients.

UR - http://www.scopus.com/inward/record.url?scp=84983085381&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983085381&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84983085381

VL - 41

SP - 36

EP - 40

JO - U.S. Pharmacist

JF - U.S. Pharmacist

SN - 0148-4818

ER -